Literature DB >> 22157868

Transferrin antibodies into the brain.

Mark S Dennis1, Ryan J Watts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22157868      PMCID： PMC3238078          DOI： 10.1038/npp.2011.196

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  5 in total

1.  Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.

Authors:  P M Friden; L R Walus; G F Musso; M A Taylor; B Malfroy; R M Starzyk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 2.  Blood-brain barrier transport of therapeutics via receptor-mediation.

Authors:  Angela R Jones; Eric V Shusta
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

3.  Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target.

Authors:  Y Joy Yu; Yin Zhang; Margaret Kenrick; Kwame Hoyte; Wilman Luk; Yanmei Lu; Jasvinder Atwal; J Michael Elliott; Saileta Prabhu; Ryan J Watts; Mark S Dennis
Journal:  Sci Transl Med       Date:  2011-05-25       Impact factor: 17.956

4.  Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.

Authors:  T Moos; E H Morgan
Journal:  J Neurochem       Date:  2001-10       Impact factor: 5.372

5.  Iron and transferrin uptake by brain and cerebrospinal fluid in the rat.

Authors:  A Crowe; E H Morgan
Journal:  Brain Res       Date:  1992-10-02       Impact factor: 3.252
  5 in total
  7 in total

1.  Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the Brain and Fatal Neuroinflammation.

Authors:  Sang-Soo Kim; Antonina Rait; Emilio R Garrido-Sanabria; Kathleen F Pirollo; Joe B Harford; Esther H Chang
Journal:  Mol Ther       Date:  2017-10-10       Impact factor: 11.454

2.  Structure and Function of the Blood-Brain Barrier (BBB).

Authors:  Fabienne Benz; Stefan Liebner
Journal:  Handb Exp Pharmacol       Date:  2022

Review 3.  Delivery of therapeutic peptides and proteins to the CNS.

Authors:  Therese S Salameh; William A Banks
Journal:  Adv Pharmacol       Date:  2014-08-22

Review 4.  Structure and dynamics of drug carriers and their interaction with cellular receptors: focus on serum transferrin.

Authors:  Ashley N Luck; Anne B Mason
Journal:  Adv Drug Deliv Rev       Date:  2012-11-23       Impact factor: 15.470

Review 5.  Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma.

Authors:  Emily Padfield; Hayley P Ellis; Kathreena M Kurian
Journal:  Front Oncol       Date:  2015-01-29       Impact factor: 6.244

6.  Novel multispecific heterodimeric antibody format allowing modular assembly of variable domain fragments.

Authors:  Timothy J Egan; Dania Diem; Richard Weldon; Tessa Neumann; Sebastian Meyer; David M Urech
Journal:  MAbs       Date:  2016-10-27       Impact factor: 5.857

7.  Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme.

Authors:  Annie Arguello; Cathal S Mahon; Meredith E K Calvert; Darren Chan; Jason C Dugas; Michelle E Pizzo; Elliot R Thomsen; Roni Chau; Lorna A Damo; Joseph Duque; Meng Fang; Tina Giese; Do Jin Kim; Nicholas Liang; Hoang N Nguyen; Hilda Solanoy; Buyankhishig Tsogtbaatar; Julie C Ullman; Junhua Wang; Mark S Dennis; Dolores Diaz; Kannan Gunasekaran; Kirk R Henne; Joseph W Lewcock; Pascal E Sanchez; Matthew D Troyer; Jeffrey M Harris; Kimberly Scearce-Levie; Lu Shan; Ryan J Watts; Robert G Thorne; Anastasia G Henry; Mihalis S Kariolis
Journal:  J Exp Med       Date:  2022-02-28       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.